Preview

Пульмонология

Расширенный поиск

Респираторная инфекция и бронхиальная астма

https://doi.org/10.18093/0869-0189-2008-0-5-75-79

Полный текст:

Об авторах

Г. Э. Хаптхаева
ФГУ НИИ пульмонологии ФМБА России
Россия
Москва


А. Г. Чучалин
ФГУ НИИ пульмонологии ФМБА России
Россия
Москва


Список литературы

1. Чучалин А.Г. (ред.) Глобальная стратегия лечения и профилактики бронхиальной астмы (GINA). М.: Атмосфера; 2002.

2. Глобальная стратегия лечения и профилактики бронхиальной астмы (GINA). Пер. с англ. М.: Атмосфера; 2006.

3. Княжеская Н.П. Тяжелая бронхиальная астма. Consilium medicum 2002; 4 (4): 189.

4. Чучалин А.Г. Тяжелая бронхиальная астма. Рус. мед. журн. 2000; 8 (12): 484.

5. Matsuse T., Hayashi S., Kuwano K. et al. Latent adenoviral infection in the pathogenesis of chronic airway obstruction. Am. Rev. Respir. Dis. 1992; 148: 177–184.

6. Macek V., Sorli J., Kopriva S., Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am. J. Respir. Crit. Care Med. 1994; 150: 7–10.

7. Bramley A.M., Vitalis T.Z., Wiggs B.R., Hegele R.G. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guineapigs. Eur. Respir. J. 1999; 14: 1061–1067.

8. Dakhama A., Vitalis T.Z., Hegele R.G. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur. Respir. J. 1997; 10: 20–26.

9. Cunningham A.F., Johnston S.L., Julious S.A. et al. Chronic Chlamydia pneumonia infection and asthma exacerbations in children. Eur. Respir. J. 1998; 11: 345–349.

10. Kraft M., Cassell G.H., Henson J.E. et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 1998; 158: 998–1001.

11. Wennergren G., Kristjansson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airways diseases. Eur. Respir. J. 2000; 13: 1044–1058.

12. Hahn D.L. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann. Allergy Asthma Immunol. 1999; 83: 271–288.

13. Norzila M.Z., Fakes K., Henry R.L. et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am. J. Respir. Crit. Care Med. 2000; 161: 769–774.

14. Fahy J.V., Kim K.W., Liu J. et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 1995; 95: 843–852.

15. Lamblin C., Gosset C., Tillie0LeBlond I. et al. Bronchial neutrophilia in patients with non-infectious status asthmaticus. Am. J. Respir. Crit. Care Med. 1998; 157: 394–402.

16. Tillie0LeBlond I., Pugin J., Marquette C.H. et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 1999; 159: 487–494.

17. Corrigan C.J., Hartnell A., Kay A.B. T lymphocyte activation in acute severe asthma. Lancet 1988; 1: 129–132.

18. O'Sullivan S., Cormican L., Faul J.L. et al. Activated, cytotoxic CD8( + ) T lymphocytes contribute to the pathology of asthma death. Am. J. Respir. Crit. Care Med. 2001; 164: 560–564.

19. Carroll N.G., Mutavdzic S., James A.L. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002; 57: 677–682.

20. Zimmermann N., Hershey G.K., Foster P.S. et al. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy Clin. Immunol. 2003; 111: 227–242.

21. Hays S.R., Fahy J.V. The role of mucus in fatal asthma. Am. J. Med. 2003; 115: 68.

22. Kuyper L.M., Pare P.D., Hogg J.C. et al. Characterization of airway plugging in fatal asthma. Am. J. Med. 2003; 115: 6–11.

23. Carlsen K.H., Orstavik I., Lecgaard J. et al. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch. Dis. Child 1984; 59: 310–315.

24. Moulder J.W., Hatch T.P., Kuo C.C. et al. Genus Chlamydia. In: Kieg N.R., Holt J., eds. Bergey's Manual of Systematic Bacteriology; vol. 1. Baltimore: The Williams and Wilkins Co.; 1984. 729–739.

25. Hatch T.P. Metabolism of Chlamydia. In: Barron A.L., ed. Microbiology of Chlamydia. Florida: CRC Press Inc.; 1988. 98–109.

26. Theunissen H.J., Lemmens0den Toom N.A., Burggraaf A. et al. Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols. Appl. Environ. Microbiol. 1993; 59: 2589–2593.

27. Grissell T.V., Powell H., Shaffren D.R. et al. Interleukin-10 gene expression in acute virus-induced asthma. Am. J. Respir. Crit. Care Med. 2005; 172: 433–439.

28. Moulder J.W., Hatch T.P., Kuo C.C. et al. Genus Chlamydia. In: Kieg N.R., Holt J., eds. Bergey's Manual of Systematic Bacteriology; vol. 1. Baltimore: The Williams and Wilkins Co.; 1984. 729–739.

29. Hatch T.P. Metabolism of Chlamydia. In: Barron A.L., ed. Microbiology of Chlamydia. Florida: CRC Press Inc.; 1988. 98–109.

30. Carlsen K.H., Orstavik I., Lecgaard J. et al. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch. Dis. Child. 1984; 59: 310–315.

31. Johnston S.L., Pattemore P.K., Sanderson G. et al. Community study of the role of viral infections in exacerbations of asthma in 9–11 year old children. Brit. Med. J. 1995; 310: 1225–1228.

32. Rakes G.P., Arruda E., Ingram J.M. et al. Rhinovirus and respiratory syncytial virus virus in wheezing children requiring emergency care. IgE and eosinophil analysis. Am. J. Respir. Crit. Care Med. 1999; 159: 785–790.

33. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. Brit. Med. J. 1993; 307: 982–986.

34. Papadopoulos N.G., Johnston S.L. The role of viruses in the induction and progression of asthma. Curr. Allergy Asthma Rep. 2001; 1: 144–152.

35. Gern J.E., Galagan D.M., Jarjour N.N. et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am. J. Respir. Crit. Care Med. 1997; 155: 1159–1161.

36. Papadopoulos N.G., Bates P.J., Bardin P.G. et al. Rhinoviruses infect the lower airways. J. Infect. Dis. 2000; 181: 1875–1884.

37. Subauste M.C., Jacoby D.B., Richards S.M. et al. Infection of human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 1995; 96: 549–557.

38. Schroth M.K., Grimm E., Frindt P. et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 1220–1228.

39. Mosser A.G., Brockman0Schneider R., Amineva S. et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J. Infect. Dis. 2002; 185: 734–743.

40. Lopez0Souza N., Dolganov G., Dubin R. et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am. J. Phyiol. Lung Cell. Mol. Physiol. 2004; 286: L373–L381.

41. Terajima M., Yamaya M., Sekizawa K. et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am. J. Phyiol. Lung Cell. Mol. Physiol. 1997; 273: L749–L759.

42. Grissell T.V., Powell H., Shaffren D.R. et al. Interleukin-10 gene expression in acute virus-induced asthma. Am. J. Respir. Crit. Care Med. 2005; 172: 433–439.

43. Bernstein J.A., Alexis N., Barnes C. et al. Health effects of air pollution. J. Allergy Clin. Immunol. 2004; 114: 1116–1123.

44. Nightingale J.A., Roger D.F., Barnes P.J. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax 2005; 54: 1061–1069.

45. McConnell R., Berhane K., Gilliland F. et al. Prospective study of air pollution and bronchitis symptoms in children with asthma. Am. J. Respir. Crit. Care Med. 2003; 168: 790–797.

46. Chauhan A., Inskip H.M., Linaker C.H. et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus induced asthma in children. Lancet 2003; 361: 1939–1944.

47. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–436.

48. Ramirez F., Fowell D.J., Puklavec M. et al. Glucocorticoids promote a Th2 cytokine response by CD4z T cells in vitro. J. Immunol. 1996; 156: 2406–2412.

49. DeKruyff R.H., Fang Y., Umetsu D.T. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4zlymphocytes by inhibiting IL-12 production. J. Immunol. 1998; 160: 2231–2237.

50. Norbiato G., Bevilacqua M., Vago T., Clerici M. Glucocorticoids and Th1, Th2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin. Exp. Rheumatol. 1997; 15: 315–323.

51. Wu C.Y., Fargeas C., Nakajima T., Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 1991; 21: 2645–2647.

52. Umland S.P., Nahrebne D.K., Razac S. et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5 and interferon-c production by cultured primary CD4zT cells. J. Allergy Clin. Immunol. 1997; 100: 511–519.

53. Laitinen K., Laurila A.L., Leinonen M., Saikku P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect. Immun. 1996; 64: 1488–1490.


Для цитирования:


Хаптхаева Г.Э., Чучалин А.Г. Респираторная инфекция и бронхиальная астма. Пульмонология. 2008;(5):75-79. https://doi.org/10.18093/0869-0189-2008-0-5-75-79

For citation:


Khaptkhaeva G.E., Chuchalin A.G. Respiratory infections and asthma. PULMONOLOGIYA. 2008;(5):75-79. (In Russ.) https://doi.org/10.18093/0869-0189-2008-0-5-75-79

Просмотров: 41


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)